FDA OKs Marketing of Whole Slide Imaging System for Digital Pathology

The U.S. Food and Drug Administration permitted marketing of the Philips IntelliSite Pathology Solution (PIPS), a whole slide imaging (WSI) system that allows for review and interpretation of digital surgical pathology slides prepared from biopsied tissue.

According to a media release, this is the first time the FDA has permitted the marketing of a WSI system for these purposes.

“The system enables pathologists to read tissue slides digitally in order to make diagnoses, rather than looking directly

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *